Ginkgo Bioworks Holdings Balance Sheet Health
Financial Health criteria checks 6/6
Ginkgo Bioworks Holdings has a total shareholder equity of $833.1M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $1.6B and $792.2M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$730.37m |
| Equity | US$833.07m |
| Total liabilities | US$792.18m |
| Total assets | US$1.63b |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: DNA *'s short term assets ($783.4M) exceed its short term liabilities ($166.2M).
Long Term Liabilities: DNA *'s short term assets ($783.4M) exceed its long term liabilities ($626.0M).
Debt to Equity History and Analysis
Debt Level: DNA * is debt free.
Reducing Debt: DNA * has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: DNA * has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: DNA * has sufficient cash runway for 2.1 years if free cash flow continues to reduce at historical rates of 19.5% each year.